Morlock G P, Plikaytis B B, Crawford J T
National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.
Antimicrob Agents Chemother. 2000 Dec;44(12):3298-301. doi: 10.1128/AAC.44.12.3298-3301.2000.
Resistance to rifampin in Mycobacterium tuberculosis results from mutations in the gene coding for the beta subunit of RNA polymerase (rpoB). At least 95% of rifampin-resistant isolates have mutations in rpoB, and the mutations are clustered in a small region. About 40 distinct point mutations and in-frame insertions and deletions in rpoB have been identified, but point mutations in two codons, those coding for Ser(531) and His(526), are seen in about 70% of rifampin-resistant clinical isolates, with Ser(531)-to-Leu (TCG-to-TGG) mutations being by far the most common. To explore this phenomenon, we isolated independent, spontaneous, rifampin-resistant mutant versions of well-characterized M. tuberculosis laboratory strain H37Rv by plating 100 separate cultures, derived from a single low-density inoculum, onto rifampin-containing medium. Rifampin-resistant mutants were obtained from 64 of these cultures. Although we anticipated that the various point mutations would occur with approximately equal frequencies, sequencing the rpoB gene from one colony per plate revealed that 39 (60.9%) were Ser(531) to Leu. We conclude that, for unknown reasons, the associated rpoB mutation occurs at a substantially higher rate than other rpoB mutations. This higher mutation rate may contribute to the high percentage of this mutation seen in clinical isolates.
结核分枝杆菌对利福平的耐药性源于编码RNA聚合酶β亚基(rpoB)的基因突变。至少95%的耐利福平菌株rpoB存在突变,且这些突变集中在一个小区域。已鉴定出rpoB中约40种不同的点突变、框内插入和缺失,但在约70%的耐利福平临床分离株中可观察到两个密码子的点突变,即编码Ser(531)和His(526)的密码子,其中Ser(531)突变为Leu(TCG突变为TGG)的突变最为常见。为探究这一现象,我们通过将来自单个低密度接种物的100个独立培养物接种到含利福平的培养基上,分离出了特征明确的结核分枝杆菌实验室菌株H37Rv的独立、自发、耐利福平突变体。从其中64个培养物中获得了耐利福平突变体。尽管我们预期各种点突变会以大致相同的频率发生,但对每个平板上一个菌落的rpoB基因进行测序发现,39个(60.9%)是Ser(531)突变为Leu。我们得出结论,由于未知原因,相关的rpoB突变发生率远高于其他rpoB突变。这种较高的突变率可能导致临床分离株中该突变的高比例出现。